Seres Therapeutics, Inc. announced the appointment of Meryl Zausner to its Board of Directors. Meryl Zausner previously served as chief financial and administrative officer of Novartis Pharmaceuticals Corporation and a member of the U.S. Pharmaceutical Executive Committee and Global Finance Leadership Team. Ms. Zausner is also currently a board member and chair of the audit committee for Neon Therapeutics, Inc. and the Multiple Myeloma Research Foundation.